Stockreport

Legend Biotech Reports Third Quarter 2024 Results and Recent Highlights

Legend Biotech Corporation - American Depositary Shares  (LEGN) 
PDF CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) updates: Net trade sales of approximately $286 million, representing operational growth of 87.6% year-over-year and 53. [Read more]